[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:thymus-carcinoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":67,"states":68},"Thymus Carcinoma",9,6,[8,16,23,29,35,41,47,54,61],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT03295227","Pembrolizumab in Treating Participants With Unresectable Thymoma or Thymic Cancer",[12],"Phase 1","RECRUITING","2026-08-26T02:17:00.709807Z","2026-05-05T02:43:29.506198Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05104736","PT-112 in Subjects With Thymoma and Thymic Carcinoma",[20],"Phase 2","2026-08-26T02:15:09.079045Z","2026-05-05T02:43:29.500865Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06980077","Ivonescimab for the Treatment of Thymic Cancer",[20],"2026-08-26T02:15:34.659160Z","2026-05-05T02:43:27.813368Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06248515","A Phase II Trial of Sacituzumab Govitecan in Patients With Advanced Thymic Epithelial Tumors",[20],"2026-08-26T02:16:21.385056Z","2026-05-05T02:43:27.059664Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07132918","HEARTS Trial for Thoracic Cancers",[20],"2026-08-26T02:16:59.895916Z","2026-05-05T02:43:29.372446Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT00242723","Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining",[],"2026-08-26T02:17:18.747857Z","2026-07-24T01:27:14.927794Z",{"nct_id":48,"title":49,"phases":50,"status":51,"updated_at":52,"content_modified":53},"NCT01385722","Molecular Analysis of Thoracic Malignancies",[],"ENROLLING_BY_INVITATION","2026-08-26T02:17:16.126291Z","2026-06-16T05:54:07.945274Z",{"nct_id":55,"title":56,"phases":57,"status":58,"updated_at":59,"content_modified":60},"NCT07118176","Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers",[12],"ACTIVE_NOT_RECRUITING","2026-08-03T03:24:20.303158Z","2026-05-05T02:43:28.732453Z",{"nct_id":62,"title":63,"phases":64,"status":58,"updated_at":65,"content_modified":66},"NCT06396598","Electronic Symptom Monitoring Program for Triggered Palliative Referrals in Patients With Thoracic Cancer",[],"2026-08-03T03:02:05.931134Z","2026-04-29T02:57:57.104461Z",[],[69],{"state":70,"count":71,"slug":72},"California",4,"california"]